Mangoceuticals, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $168 | $109 | $105 | $133 |
Gross Profit | 89 | 62 | 80 | 82 |
EBITDA | -4,557 | -4,853 | -1,677 | -1,758 |
EBIT | -5,394 | -5,267 | -2,398 | -1,758 |
Net Income | -5,415 | -4,839 | -1,948 | -1,999 |
Net Change In Cash | 168 | 109 | 105 | 133 |
Free Cash Flow | -1,256 | -2,274 | -1,129 | -1,165 |
Cash | 101 | 76 | 58 | 73 |
Basic Shares | 9,983 | 1,979 | 1,979 | 2,014 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $615 | $731 | $8 |
Gross Profit | 379 | 431 | 4 |
EBITDA | -7,962 | -9,188 | -1,987 |
EBIT | -8,683 | -9,212 | -1,991 |
Net Income | -8,706 | -9,212 | -1,998 |
Net Change In Cash | 615 | 731 | 8 |
Free Cash Flow | -4,863 | -7,000 | -1,389 |
Cash | 58 | 739 | 682 |
Basic Shares | 1,979 | 1,074 | 1,021 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.57 |
2025-03-31 | -$1.05 |
2024-12-31 | -$1.08 |
2024-09-30 | -$0.99 |
